Patent Assignment
Reel/Frame 028401/0688
Security Agreement
Recorded: 2012-06-19
Pages: 8
Assignors
AGI THERAPEUTICS PUBLIC LIMITED COMPANY
Executed: 2012-06-19
VIDARA THERAPEUTICS RESEARCH LIMITED
Executed: 2012-06-19
Assignee
GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
500 WEST MONROE STREET, CHICAGO, ILLINOIS, 60661
Covered Properties
(5)
Manufacture and Expression of Large Structural Genes
Patent:
6,936,694 →
Application:
06/483,451 →
Manufacture and Expression of Large Structural Genes
Patent:
6,936,695 →
Application:
08/462,022 →
Treatment of Abnormal Increases in Gastrointestinal Motility with (R)-Verapamil
Manufacture and Expression of Large Structural Genes
Patent:
39,821 →
Application:
11/234,817 →
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Application:
12/724,652 →
Publication:
US 2010/0196479
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 8, 2008
From: KEELING, P.N.W.; DINAN, TIMOTHY
To: AGI THERAPEUTICS RESEARCH LIMITED
Reel/Frame 020478/0544 →
Change of Name
Jun 19, 2012
From: AGI THERAPEUTICS RESEARCH LIMITED
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 028401/0563 →
Change of Name
Jun 19, 2012
From: AGI THERAPEUTICS LIMITED
To: AGI THERAPEUTICS PUBLIC LIMITED COMPANY
Reel/Frame 028401/0655 →
Assignment of Assignor's Interest
Nov 9, 2012
From: INTERMUNE, INC.
To: VIDARA THERAPEUTICS INTERNATIONAL LIMITED
Reel/Frame 029269/0590 →
Assignment of Assignor's Interest
Nov 9, 2012
From: INTERMUNE, INC.
To: VIDARA THERAPEUTICS INTERNATIONAL LIMITED
Reel/Frame 029269/0572 →
Release of Security Interest
Mar 17, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED; AGI THERAPEUTICS, LTD. (F/K/A AGI THERAPEUTICS PLC)
Reel/Frame 032452/0237 →
Release of Security Interest
Apr 2, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 032578/0993 →
Security Interest
May 7, 2015
From: HORIZON PHARMA SERVICES LIMITED (FORMERLY KNOWN AS AGI THERAPEUTICS PUBLIC LIMITED COMPANY); HORIZON PHARMA IRELAND LIMITED (FORMERLY KNOWN AS VIDARA THERAPEUTICS RESEARCH LIMITED)
To: CITIBANK, N.A.
Reel/Frame 035590/0950 →
Change of Name
Aug 12, 2015
From: VIDARA THERAPEUTICS RESEARCH LIMITED
To: HORIZON PHARMA IRELAND LIMITED
Reel/Frame 036309/0919 →
Change of Name
Aug 12, 2015
From: VIDARA THERAPEUTICS INTERNATIONAL PUBLIC LIMITED COMPANY
To: HORIZON PHARMA PUBLIC LIMITED COMPANY
Reel/Frame 036309/0817 →
Change of Name
Aug 12, 2015
From: AGI THERAPEUTICS LIMITED
To: HORIZON PHARMA SERVICES LIMITED
Reel/Frame 036309/0553 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS IRELAND DAC (SUCCESSOR IN INTEREST TO HORIZON PHARMA SERVICES LIMITED); HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED); HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED
Reel/Frame 065153/0953 →